Target
Proto-oncogene tyrosine-protein kinase Src
Ligand
BDBM50221547
Substrate
n/a
Meas. Tech.
ChEMBL_473234 (CHEMBL932925)
IC50
1.5±n/a nM
Citation
 Palanki, MSAkiyama, HCampochiaro, PCao, JChow, CPDellamary, LDoukas, JFine, RGritzen, CHood, JDHu, SKachi, SKang, XKlebansky, BKousba, ALohse, DMak, CCMartin, MMcPherson, APathak, VPRenick, JSoll, RUmeda, NYee, SYokoi, KZeng, BZhu, HNoronha, G Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration. J Med Chem 51:1546-59 (2008) [PubMed]  Article 
Target
Name:
Proto-oncogene tyrosine-protein kinase Src
Synonyms:
Calmodulin/Proto-oncogene tyrosine-protein kinase Src | Protein cereblon/Tyrosine-protein kinase SRC | Proto-oncogene c-Src | Proto-oncogene tyrosine-protein kinase Src (c-Src) | SRC | SRC1 | SRC_HUMAN | Tyrosine-protein kinase Src (SRC) | V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | c-Src | p60-Src | pp60c-src
Type:
Protein
Mol. Mass.:
59838.60
Organism:
Homo sapiens (Human)
Description:
P12931
Residue:
536
Sequence:
MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
  
Inhibitor
Name:
BDBM50221547
Synonyms:
4-chloro-3-(5-methyl-3-(4-(3-(pyrrolidin-1-yl)propyl)phenylamino)benzo[e][1,2,4]triazin-7-yl)phenol | 7-(2-chloro-5-hydroxyphenyl)-5-methyl-N-[4-(3-pyrrolidin-1-ylpropyl)]phenyl]-1,2,4-benzotriazin-3-amine | CHEMBL250213
Type:
Small organic molecule
Emp. Form.:
C27H28ClN5O
Mol. Mass.:
473.997
SMILES:
Cc1cc(cc2nnc(Nc3ccc(CCCN4CCCC4)cc3)nc12)-c1cc(O)ccc1Cl
Structure:
Search PDB for entries with ligand similarity: